{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:52:19Z","timestamp":1792187539588,"version":"4.4.0"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The potential impact of ankylosing spondylitis (AS) on cancer risk remains unclear. This study seeks to investigate the relationship between AS and different types of cancers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A literature search on PubMed, EMBASE and Cochrane Library up to 10 July 2023 was conducted. Two investigators selected eligible studies and extracted relevant data. The study used the random-effects model to explore the causality between AS and cancer, utilizing relative risk (RR) as a measure for the study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 20 cohorts with &amp;gt;330\u2009000 participants were included. The pooling analysis shows AS being associated with a higher risk of cancers (RR\u2009=\u20091.16, 95% CI: 1.07\u20131.26, P\u2009=\u20090.001, I2\u2009=\u200970.60%). In the subgroup analysis, AS has a higher cancer risk in Asia, but this association is not significant in Europe. Individual investigations indicate that AS is associated with an increased risk of bone cancer (RR\u2009=\u20093.41, 95% CI: 1.45\u20137.99, P\u2009=\u20090.005, I2\u2009=\u20090.00%), thyroid gland cancer (RR\u2009=\u20091.76, 95% CI: 1.29\u20132.40, P\u2009&amp;lt;\u20090.001, I2\u2009=\u200913.70%), multiple myeloma (RR\u2009=\u20091.74, 95% CI: 1.42\u20132.15, P\u2009&amp;lt;\u20090.001, I2\u2009=\u200927.20%), leukaemia (RR\u2009=\u20091.52, 95% CI: 1.27\u20131.82, P\u2009&amp;lt;\u20090.001, I2\u2009=\u20090.00%), kidney cancer (RR\u2009=\u20091.45, 95% CI: 1.08\u20131.94, P\u2009=\u20090.014, I2\u2009=\u20090.00%), prostate cancer (RR\u2009=\u20091.43, 95% CI: 1.17\u20131.74, P\u2009&amp;lt;\u20090.001, I2\u2009=\u200982.80%) and non-Hodgkin\u2019s lymphoma (RR\u2009=\u20091.42, 95% CI: 1.17\u20131.73, P\u2009&amp;lt;\u20090.001, I2\u2009=\u20090.00%). However, there is no significant correlation with connective tissue cancer, brain cancer, testicular and other male cancers, bladder cancer, female cancers, skin cancer, and cancers of the digestive system and respiratory system.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>AS appears to be related to cancer development. The results highlighted the necessity for large-scale studies, considering influencing factors such as AS course, medication histories and potential biases when examining cancer risk.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae294","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T20:51:47Z","timestamp":1717447907000},"page":"440-454","source":"Crossref","is-referenced-by-count":15,"title":["Association of ankylosing spondylitis with the risk of cancer: a meta-analysis of cohort studies"],"prefix":"10.1093","volume":"64","author":[{"given":"Lulin","family":"Yu","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine) , Hangzhou,","place":["China"]},{"name":"The First School of Clinical Medicine, Zhejiang Chinese Medical University , Hangzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yici","family":"Yan","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine) , Hangzhou,","place":["China"]},{"name":"The First School of Clinical Medicine, Zhejiang Chinese Medical University , Hangzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Liu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine) , Hangzhou,","place":["China"]},{"name":"The First School of Clinical Medicine, Zhejiang Chinese Medical University , Hangzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Huang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine) , Hangzhou,","place":["China"]},{"name":"The First School of Clinical Medicine, Zhejiang Chinese Medical University , Hangzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leitao","family":"Sun","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine) , Hangzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanming","family":"Ruan","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine) , Hangzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"key":"2025032905211133200_keae294-B1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2025032905211133200_keae294-B2","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/s41416-021-01498-4","article-title":"Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK","volume":"125","author":"Hackshaw","year":"2021","journal-title":"Br J Cancer"},{"key":"2025032905211133200_keae294-B3","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.cell.2023.03.013","article-title":"Impact of risk factors on early cancer evolution","volume":"186","author":"Weeden","year":"2023","journal-title":"Cell"},{"key":"2025032905211133200_keae294-B4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"2025032905211133200_keae294-B5","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrc3611","article-title":"Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms","volume":"13","author":"Elinav","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"2025032905211133200_keae294-B6","doi-asserted-by":"crossref","DOI":"10.1002\/wsbm.1370","article-title":"Cancer and inflammation","volume":"9","author":"Munn","year":"2017","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"2025032905211133200_keae294-B7","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"2025032905211133200_keae294-B8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/ar2669","article-title":"Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases","volume":"11","author":"Gabriel","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"2025032905211133200_keae294-B9","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","article-title":"Ankylosing spondylitis","volume":"369","author":"Braun","year":"2007","journal-title":"Lancet"},{"key":"2025032905211133200_keae294-B10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","article-title":"Axial spondyloarthritis","volume":"390","author":"Sieper","year":"2017","journal-title":"Lancet"},{"key":"2025032905211133200_keae294-B11","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1056\/NEJMra1406182","article-title":"Ankylosing spondylitis and axial spondyloarthritis","volume":"374","author":"Taurog","year":"2016","journal-title":"N Engl J Med"},{"key":"2025032905211133200_keae294-B12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41584-021-00625-y","article-title":"Ankylosing spondylitis: an autoimmune or autoinflammatory disease?","volume":"17","author":"Mauro","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"2025032905211133200_keae294-B13","doi-asserted-by":"crossref","first-page":"32063","DOI":"10.1038\/srep32063","article-title":"Risk of malignancy in ankylosing spondylitis: a systematic review and meta-analysis","volume":"6","author":"Deng","year":"2016","journal-title":"Sci Rep"},{"key":"2025032905211133200_keae294-B14","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025032905211133200_keae294-B15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"2025032905211133200_keae294-B16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.mayocp.2022.06.030","article-title":"Risk of hematologic malignancies in elderly patients with ankylosing spondylitis: a cohort study and systematic review","volume":"98","author":"Alehashemi","year":"2023","journal-title":"Mayo Clinic Proc"},{"key":"2025032905211133200_keae294-B17","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1182\/blood-2007-10-121285","article-title":"Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders","volume":"111","author":"Brown","year":"2008","journal-title":"Blood"},{"key":"2025032905211133200_keae294-B18","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.cgh.2013.11.007","article-title":"Increased risk of hepatobiliary cancers after hospitalization for autoimmune disease","volume":"12","author":"Castro","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025032905211133200_keae294-B19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/03009742.2020.1804612","article-title":"Risk of cancer in patients with ankylosing spondylitis: a nationwide cohort study in Taiwan","volume":"50","author":"Chan","year":"2021","journal-title":"Scand J Rheumatol"},{"key":"2025032905211133200_keae294-B20","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3892\/ol.2017.6368","article-title":"Ankylosing spondylitis and the risk of cancer","volume":"14","author":"Chang","year":"2017","journal-title":"Oncol Lett"},{"key":"2025032905211133200_keae294-B21","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/annonc\/mdu144","article-title":"Hodgkin lymphoma after autoimmune diseases by age at diagnosis and histological subtype","volume":"25","author":"Fallah","year":"2014","journal-title":"Ann Oncol"},{"key":"2025032905211133200_keae294-B22","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/ard.2002.004721","article-title":"Cancer incidence among patients with ankylosing spondylitis in Sweden 1965-95: a population based cohort study","volume":"62","author":"Feltelius","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"2025032905211133200_keae294-B23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/annrheumdis-2016-209270","article-title":"Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers","volume":"76","author":"Hellgren","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2025032905211133200_keae294-B24","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/art.38339","article-title":"Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden","volume":"66","author":"Hellgren","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2025032905211133200_keae294-B25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1756-8722-5-59","article-title":"Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma","volume":"5","author":"Hemminki","year":"2012","journal-title":"J Hematol Oncol"},{"key":"2025032905211133200_keae294-B26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ygyno.2012.07.100","article-title":"Effect of autoimmune diseases on risk and survival in female cancers","volume":"127","author":"Hemminki","year":"2012","journal-title":"Gynecol Oncol"},{"key":"2025032905211133200_keae294-B27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/annonc\/mdr333","article-title":"Autoimmune disease and subsequent digestive tract cancer by histology","volume":"23","author":"Hemminki","year":"2012","journal-title":"Ann Oncol"},{"key":"2025032905211133200_keae294-B28","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1002\/ijc.29657","article-title":"Risk of cancer of unknown primary after hospitalization for autoimmune diseases","volume":"137","author":"Hemminki","year":"2015","journal-title":"Int J Cancer"},{"key":"2025032905211133200_keae294-B29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/1756-185X.14036","article-title":"Cancer diagnosis and mortality in patients with ankylosing spondylitis: a Western Australian retrospective cohort study","volume":"24","author":"Kelty","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"2025032905211133200_keae294-B30","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1182\/blood-2011-04-347559","article-title":"Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study","volume":"118","author":"Lindqvist","year":"2011","journal-title":"Blood"},{"key":"2025032905211133200_keae294-B31","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.juro.2012.12.014","article-title":"Autoimmune disease and subsequent urological cancer","volume":"189","author":"Liu","year":"2013","journal-title":"Journal of Urology"},{"key":"2025032905211133200_keae294-B32","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00296-019-04408-3","article-title":"Malignancy risk in Korean male patients with ankylosing spondylitis","volume":"39","author":"Nam","year":"2019","journal-title":"Rheumatol Int"},{"key":"2025032905211133200_keae294-B33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/03009742.2013.863969","article-title":"Increased risk of cancer for patients with ankylosing spondylitis: a nationwide population-based retrospective cohort study","volume":"43","author":"Sun","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"2025032905211133200_keae294-B34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10067-017-3676-8","article-title":"Malignancy as a comorbidity in rheumatic diseases: a retrospective hospital-based study","volume":"37","author":"Wang","year":"2018","journal-title":"Clin Rheumatol"},{"key":"2025032905211133200_keae294-B35","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1093\/rheumatology\/keaa166","article-title":"Risks of solid cancers in elderly persons with osteoarthritis or ankylosing spondylitis","volume":"59","author":"Ward","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2025032905211133200_keae294-B36","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"2025032905211133200_keae294-B37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.rdc.2017.09.004","article-title":"Gastrointestinal and hepatic disease in spondyloarthritis","volume":"44","author":"Caplan","year":"2018","journal-title":"Rheum Dis Clin North Am"},{"key":"2025032905211133200_keae294-B38","doi-asserted-by":"crossref","first-page":"836533","DOI":"10.3389\/fimmu.2022.836533","article-title":"Osteoarticular involvement-associated biomarkers and pathways in psoriasis: the shared pathway with ankylosing spondylitis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"2025032905211133200_keae294-B39","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s40265-022-01750-y","article-title":"Spondyloarthropathy in inflammatory bowel disease: from pathophysiology to pharmacological targets","volume":"82","author":"Crispino","year":"2022","journal-title":"Drugs"},{"key":"2025032905211133200_keae294-B40","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41584-018-0006-8","article-title":"Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison","volume":"14","author":"Feld","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2025032905211133200_keae294-B41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bbrc.2011.03.021","article-title":"IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma","volume":"407","author":"Liu","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"2025032905211133200_keae294-B42","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.lungcan.2009.11.013","article-title":"Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients","volume":"69","author":"Chen","year":"2010","journal-title":"Lung Cancer"},{"key":"2025032905211133200_keae294-B43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ijc.20373","article-title":"Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome)","volume":"112","author":"Ciree","year":"2004","journal-title":"Int J Cancer"},{"key":"2025032905211133200_keae294-B44","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fmed.2018.00080","article-title":"Spondyloarthritis, acute anterior uveitis, and fungi: updating the catterall-king hypothesis","volume":"5","author":"Laurence","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"2025032905211133200_keae294-B45","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3748\/wjg.v22.i2.501","article-title":"Gut microbiota imbalance and colorectal cancer","volume":"22","author":"Gagniere","year":"2016","journal-title":"World J Gastroenterol"},{"key":"2025032905211133200_keae294-B46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1126\/science.abc4552","article-title":"The microbiome and human cancer","volume":"371","author":"Sepich-Poore","year":"2021","journal-title":"Science"},{"key":"2025032905211133200_keae294-B47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/hmg\/ddaa272","article-title":"SNP-adjacent super enhancer network mediates enhanced osteogenic differentiation of MSCs in ankylosing spondylitis","volume":"30","author":"Yu","year":"2021","journal-title":"Hum Mol Genet"},{"key":"2025032905211133200_keae294-B48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/BOR.0000000000000945","article-title":"Evidence in support of the bone marrow as the primary lesion in axial spondyloarthritis","volume":"35","author":"Maksymowych","year":"2023","journal-title":"Curr Opin Rheumatol"},{"key":"2025032905211133200_keae294-B49","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jamadermatol.2019.3056","article-title":"Association of psoriasis with the risk of developing or dying of cancer: a systematic review and meta-analysis","volume":"155","author":"Trafford","year":"2019","journal-title":"JAMA Dermatol"},{"key":"2025032905211133200_keae294-B50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.semcancer.2019.05.001","article-title":"Risk of colorectal cancer in inflammatory bowel diseases","volume":"64","author":"Nadeem","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"2025032905211133200_keae294-B51","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.semarthrit.2021.09.009","article-title":"Risk of malignancy in patients with systemic lupus erythematosus: systematic review and meta-analysis","volume":"51","author":"Clarke","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"2025032905211133200_keae294-B52","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3322\/canjclin.33.6.322","article-title":"Prostaglandins and cancer","volume":"33","author":"Karmali","year":"1983","journal-title":"CA Cancer J Clin"},{"key":"2025032905211133200_keae294-B53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1054-3589(08)60067-8","article-title":"Colorectal cancer and nonsteroidal anti-inflammatory drugs","volume":"39","author":"Smalley","year":"1997","journal-title":"Adv Pharmacol"},{"key":"2025032905211133200_keae294-B54","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1470-2045(07)70146-8","article-title":"Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study","volume":"8","author":"Gridelli","year":"2007","journal-title":"Lancet Oncol"},{"key":"2025032905211133200_keae294-B55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000071364","article-title":"Epidemiology of non-steroidal anti-inflammatory drugs and cancer","volume":"37","author":"Baron","year":"2003","journal-title":"Prog Exp Tumor Res"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae294\/59018816\/keae294.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/2\/440\/59018816\/keae294.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/2\/440\/59018816\/keae294.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T03:30:48Z","timestamp":1743391848000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/2\/440\/7687078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,6,3]]},"published-print":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae294","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,6,3]]}}}